Newborn Screening Using Genome Sequencing for Early Actionable Conditions—Reply

In Reply The comments from Dr Wu and colleagues regarding our recently published article1 highlight important technical, clinical, and ethical considerations in the use of genomic sequencing for newborn screening.

Authors

Alban Ziegler (ORCID: https://orcid.org/0000-0003-0287-3561)
Wendy K. Chung

Institutions

Boston Children's Hospital (US)
Harvard University (US)

Publication Details

Journal: JAMA
Published: 2025-02-24
DOI: https://doi.org/10.1001/jama.2024.27289
Citations: 6
Primary Topic: Genomics and Rare Diseases
Type: article
Field-Weighted Citation Impact: 10.90

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Newborn Screening Using Genome Sequencing for Early Actionable Conditions—Reply

Alban Ziegler, Wendy K. Chung

Feb 24, 2025

6 citations

JAMA

Genomics and Rare Diseases

10.90

article

Newborn Screening Using Genome Sequencing for Early Actionable Conditions—Reply

Alban Ziegler, Wendy K. Chung

February 24, 2025article en

6 citations

Abstract

JAMAVol. 333(12)

Boston Children's Hospital (US), Harvard University (US)

Zero hunger

Openalex Percentile: Top 2%

Genomics and Rare Diseases

10.90

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Newborn Screening Using Genome Sequencing for Early Actionable Conditions—Reply — Alban Ziegler, Wendy K. Chung · JAMA (2025) | TGRS Research Map | TGRS